Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Lamisil®

terbinafine (terbinafine hydrochloride)

Infectious disease

Established Medicines

USA Germany Australia United Kingdom Poland Canada Turkey

Lescol®

fluvastatin sodium

Cardiovascular, Renal and Metabolism

Established Medicines

Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lescol® XL

fluvastatin sodium

Cardiovascular, Renal and Metabolism

Established Medicines

Global Product Site USA Australia United Kingdom Austria Poland Netherlands Canada

Lucentis®

ranibizumab

Ophthalmology

Ophthalmology

Global Product Site Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Lutathera®

lutetium Lu 177 dotatate

Advanced Accelerator Applications

USA USA Product Site

Luxturna®

voretigene neparvovec

Ophthalmology

Ophthalmology

USA Product Site USA